Michael Hoffmann, Angel Investor

Michael B. Hoffman is an angel investor focused on biotechnology and life sciences. His investments include Annovis Bio, a clinical-stage biopharmaceutical company developing therapies for neurodegenerative diseases. His investment activity has included a Post-IPO Equity investment, where Annovis Bio raised a total of $3.4 million. He has participated in supporting a publicly traded biotechnology company. Michael has served as Vice President and Managing Director of Arizona Biltmore since 2024. Previously, he was Managing Director of LXR Hotels & Resorts and Inn at Perry Cabin.